Company Filing History:
Years Active: 2010-2020
Title: Innovations by Vincent Segers in Tissue Repair
Introduction
Vincent Segers is an accomplished inventor based in Cambridge, MA, known for his significant contributions to the field of tissue repair. With a total of four patents to his name, Segers has focused on developing innovative solutions that enhance the healing process.
Latest Patents
One of Segers' latest patents is centered around protease-resistant mutants of stromal cell-derived factor-1 (SDF-1). This invention involves peptides that have been mutated to resist digestion by proteases such as dipeptidyl peptidase IV (DPPIV) and matrix metalloproteinase-2 (MMP-2). Despite these modifications, the mutants retain the ability of native SDF-1 to attract T cells. These peptides can be attached to membranes formed by self-assembling peptides and implanted at sites of tissue damage to promote repair.
Career Highlights
Vincent Segers is affiliated with Brigham and Women's Hospital, Inc., where he continues to work on groundbreaking research in the field of regenerative medicine. His innovative approaches have the potential to significantly impact the way tissue damage is treated.
Collaborations
Segers collaborates with Richard Theodore Lee, a fellow researcher, to further advance their work in tissue repair and regenerative therapies.
Conclusion
Vincent Segers is a notable inventor whose work in developing protease-resistant peptides for tissue repair showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies in regenerative medicine.